European Parliament Holds Key Hearing on Pharmaceutical Legislation: A Focus on Innovation, Incentives, and Patient-Centred Governance

https://www.intergrouponcancerandrarediseases.eu/news/european-parliament-holds-key-hearing-on-pharmaceutical-legislation-a-focus-on-innovation-incentives-and-patient-centred-governance European Parliament On 10 July, the European Parliament Intergroup on Cancer and Rare Diseases held a public hearing in Strasbourg to discuss progress on revising the EU pharmaceutical legislation. The session featured input from MEPs across political groups, as well as from Virginie Hivert, EURORDIS’ Head of Therapies and Access, who underscored the need to refine incentives for orphan medicinal products. EURORDIS is one of the Intergroup’s three secretariat organisations